Loading clinical trials...
Loading clinical trials...
Type 2 diabetes is spreading worldwide as well as obesity. Metformin is the most prescribed antidiabetic medication. One suggested mechanism of action is by decreasing carbohydrate absorption. It is ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Lille
NCT07286747 · Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
NCT07440147 · Obesity & Overweight, Circadian Rhythm Disorders, and more
NCT06961019 · Type2 Diabetes Mellitus
NCT03481283 · Type2 Diabetes, Peripheral Neuropathy
NCT05277558 · Type2 Diabetes, Type 2 Diabetes Mellitus in Obese, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions